What does this video actually claim?
@_life_of_eli_ responds to a comment about peptide therapy, stating that peptides are "usually taken 5 days on 2 days off but also could be taken every day." The video doesn't specify which peptides they're discussing, leaving viewers to guess whether this applies to BPC-157, TB-500, or other research compounds.
This vague approach is problematic. Different peptides have vastly different dosing protocols in research settings, and lumping them together oversimplifies things significantly.
Do peptides actually follow this dosing pattern?
The "5 days on, 2 days off" protocol isn't standard across peptide research. Most published studies use continuous daily dosing rather than cycling patterns.
For BPC-157, the most studied dosing in animal models involves daily subcutaneous injections at 10 micrograms per kilogram body weight (Sikiric et al., Journal of Physiology and Pharmacology, 2018). TB-500 research typically uses twice-weekly injections at 2-2.5mg doses over 4-6 week periods (Ruff et al., Wound Repair and Regeneration, 2010).
Growth hormone releasing peptides like CJC-1295 are often dosed 2-3 times weekly in research, not on a 5-day cycle. The creator's blanket statement doesn't match how these compounds are actually studied.
What's the problem with generic peptide advice?
Each research peptide has different pharmacokinetics, meaning they're absorbed, distributed, and eliminated at different rates. Applying the same dosing schedule to all peptides ignores basic pharmacology.
BPC-157 has a relatively short half-life and is typically dosed daily in studies. TB-500, derived from thymosin beta-4, has different kinetics and is usually dosed less frequently. CJC-1295 with DAC (drug affinity complex) can have effects lasting several days.
The "could be taken every day" addition makes the advice even more confusing. If you don't know which peptide someone is asking about, you can't give meaningful dosing guidance.
What should people actually know about peptides?
These compounds aren't approved by the FDA for human use outside of specific research contexts. The dosing protocols being discussed come from animal studies or small human trials, not established medical practice.
Most peptide research focuses on specific conditions in controlled settings. The Sikiric studies on BPC-157 examined gastric ulcers and tendon healing in rats. The TB-500 research looked at wound healing in controlled laboratory conditions.
Taking dosing advice from TikTok videos about unapproved research compounds isn't wise. If you're considering peptide therapy, work with a healthcare provider who can evaluate your specific situation and monitor for potential side effects.